-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a variety of mutant strains of the new coronavirus have been discovered all over the world
Today, Moderna announced its mRNA new coronavirus vaccine, the results of the neutralization ability of a variety of new coronavirus mutant strains including Delta
In this study, the researchers used pseudoviral vectors based on vesicular stomatitis virus (VSV) to express the spike proteins of a variety of new coronavirus mutant strains
The experimental results showed that for Alpha and the A.
For the Delta virus strain, the serum neutralization titer was reduced by 2.
Among the tested mutant strains, the Beta (B.
The researchers pointed out in the paper that although a variety of tested mutant strains led to varying degrees of reduction in serum neutralization titers of the vaccinators, they were still sensitive to the serum stimulated by mRNA-1273
▲Neutralization titer data of mRNA-1273 vaccine vaccinators against different new coronavirus mutant strains (picture source: reference [2])
Note: The original text has been deleted
Reference materials:
[1] Moderna Provides a Clinical Update on the Neutralizing Activity of its COVID-19 Vaccine on Emerging Variants Including the Delta Variant First Identified in India.
[2] Choi et al.